4.8 Article

Homeostatic Control of Mitotic Arrest

Journal

MOLECULAR CELL
Volume 44, Issue 5, Pages 710-720

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2011.11.014

Keywords

-

Funding

  1. European Union
  2. Italian Association for Cancer Research (AIRC)
  3. Fondo di Investimento per la Ricerca di Base (FIRB)
  4. Cariplo Foundation
  5. Human Frontier Science Program
  6. Programmi Integrati di Oncologia (PIO) [7/07]
  7. Italian Foundation for Cancer Research (FIRC)

Ask authors/readers for more resources

The spindle assembly checkpoint (SAC) restricts mitotic exit to cells that have completed chromosome-microtubule attachment. Cdc20 is a bifunctional protein. In complex with SAC proteins Mad2, BubR1, and Bub3, Cdc20 forms the mitotic checkpoint complex (MCC), which binds the anaphase-promoting complex (APC/C) and inhibits its mitotic exit-promoting activity. When devoid of SAC proteins, Cdc20 serves as an APC/C coactivator and promotes mitotic exit. During mitotic arrest, Cdc20 is continuously degraded via ubiquitin-dependent proteolysis and resynthesized. It is believed that this cycle keeps the levels of Cdc20 below a threshold above which Cdc20 would promote mitotic exit. We report that p31(comet), a checkpoint antagonist, is necessary for mitotic destabilization of Cdc20. p31(comet) depletion stabilizes the MCC, super-inhibits the APC/C, and delays mitotic exit, indicating that Cdc20 proteolysis in prometaphase opposes the checkpoint. Our studies reveal a homeostatic network in which checkpoint-sustaining and -repressing forces oppose each other during mitotic arrest and suggest ways for enhancing the sensitivity of cancer cells to antitubulin chemotherapeutics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available